Annual Short Term Debt
$3.16 M
+$35.00 K+1.12%
December 31, 2023
Summary
- As of March 12, 2025, GLUE annual short term debt is $3.16 million, with the most recent change of +$35.00 thousand (+1.12%) on December 31, 2023.
- GLUE annual short term debt is now at all-time high.
Performance
GLUE Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$3.65 M
+$175.00 K+5.04%
September 30, 2024
Summary
- As of March 12, 2025, GLUE quarterly short term debt is $3.65 million, with the most recent change of +$175.00 thousand (+5.04%) on September 30, 2024.
- Over the past year, GLUE quarterly short term debt has increased by +$301.00 thousand (+9.00%).
- GLUE quarterly short term debt is now at all-time high.
Performance
GLUE Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
GLUE Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.1% | +9.0% |
| 3 y3 years | - | +16.6% |
| 5 y5 years | +321.6% | +16.6% |
GLUE Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | at high | -100.0% |
| 5 y | 5-year | at high | -100.0% | at high | -100.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Monte Rosa Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.65 M(+5.0%) |
| Jun 2024 | - | $3.47 M(+3.8%) |
| Mar 2024 | - | $3.35 M(+5.8%) |
| Dec 2023 | $3.16 M | $3.16 M(+9.8%) |
| Sep 2023 | - | $2.88 M(+8.0%) |
| Jun 2023 | - | $2.67 M(-7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $2.89 M(-7.6%) |
| Dec 2022 | $3.13 M(>+9900.0%) | $3.13 M(+2.0%) |
| Sep 2022 | - | $3.06 M(+15.1%) |
| Jun 2022 | - | $2.66 M(+74.7%) |
| Mar 2022 | - | $1.52 M(>+9900.0%) |
| Dec 2021 | $0.00(-100.0%) | $0.00 |
| Dec 2019 | $750.00 K | - |
FAQ
- What is Monte Rosa Therapeutics annual short term debt?
- What is the all time high annual short term debt for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual short term debt year-on-year change?
- What is Monte Rosa Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly short term debt year-on-year change?
What is Monte Rosa Therapeutics annual short term debt?
The current annual short term debt of GLUE is $3.16 M
What is the all time high annual short term debt for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual short term debt is $3.16 M
What is Monte Rosa Therapeutics annual short term debt year-on-year change?
Over the past year, GLUE annual short term debt has changed by +$35.00 K (+1.12%)
What is Monte Rosa Therapeutics quarterly short term debt?
The current quarterly short term debt of GLUE is $3.65 M
What is the all time high quarterly short term debt for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly short term debt is $3.65 M
What is Monte Rosa Therapeutics quarterly short term debt year-on-year change?
Over the past year, GLUE quarterly short term debt has changed by +$301.00 K (+9.00%)